Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinical characteristic of infertile patients with endometriosis and controls

From: MicroRNA-451 is downregulated in the follicular fluid of women with endometriosis and influences mouse and human embryonic potential

 Endometriosis
(n = 139)
Controls
(n = 184)
P-values
Maternal age (years)33.2 ± 5.732.6 ± 5.4NS
BMI (kg/m2)22.1 ± 2.821.7 ± 2.9NS
Years of infertility4.7 ± 1.94.5 ± 1.8NS
Cycle length (days)31.4 ± 5.432.5 ± 8.9NS
Endometrial thickness (mm)10.63 ± 2.2410.56 ± 2.20NS
Proportion of IVF (%)86 (61.9)110 (59.8)NS
Proportion of ICSI (%)53 (38.1)74 (40.2)NS
Day-3 E2 (pg/ml)35.8 ± 16.336.6 ± 21.0NS
Day-3 P4 (ng/ml)0.8 ± 1.00.7 ± 0.4NS
Day-3 LH (mIU /ml)5.5 ± 4.14.6 ± 3.7NS
Day-3 FSH (mIU/ml)8.8 ± 3.37.5 ± 2.2NS
Normal fertilization rate (%)65.1 ± 25.674.6 ± 22.3< 0.01
Number of oocytes7.3 ± 4.310.7 ± 4.7< 0.01
Number of available embryos4.2 ± 2.96.7 ± 2.9< 0.01
  1. The controls were normal responders without endometriosis, who were undergoing treatment for male factor infertility. NS no significant difference. P-values: Unpaired t-test. BMI body mass index, IVF in vitro fertilization, ICSI intracytoplasmic sperm injection, E2 oestradiol, P4 progesterone, LH luteinizing hormone, FSH follicle stimulating hormone